| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 8 | 2013 | 72 | 1.760 |
Why?
|
| Mitral Valve | 17 | 2018 | 166 | 1.420 |
Why?
|
| Heart Valve Prosthesis | 23 | 2018 | 222 | 1.410 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2018 | 164 | 1.210 |
Why?
|
| Aortic Valve | 20 | 2018 | 249 | 1.120 |
Why?
|
| Myocardial Contraction | 37 | 2003 | 383 | 1.030 |
Why?
|
| Cardiac Surgical Procedures | 16 | 2014 | 450 | 1.030 |
Why?
|
| Heart Valve Diseases | 9 | 2013 | 123 | 0.920 |
Why?
|
| Tachycardia, Supraventricular | 23 | 1997 | 73 | 0.910 |
Why?
|
| Education, Medical, Graduate | 6 | 2014 | 214 | 0.900 |
Why?
|
| Societies, Medical | 4 | 2015 | 403 | 0.800 |
Why?
|
| Heart Septal Defects, Ventricular | 10 | 2009 | 59 | 0.790 |
Why?
|
| Coronary Artery Bypass | 11 | 2011 | 218 | 0.770 |
Why?
|
| Thoracic Surgical Procedures | 5 | 2013 | 37 | 0.740 |
Why?
|
| Alzheimer Disease | 11 | 2000 | 565 | 0.730 |
Why?
|
| Myocardium | 35 | 2003 | 1204 | 0.670 |
Why?
|
| Internship and Residency | 8 | 2014 | 596 | 0.640 |
Why?
|
| Thermodilution | 9 | 1992 | 20 | 0.590 |
Why?
|
| Heart Arrest, Induced | 15 | 1998 | 52 | 0.570 |
Why?
|
| Vascular Surgical Procedures | 3 | 2011 | 168 | 0.560 |
Why?
|
| Humans | 161 | 2018 | 68618 | 0.560 |
Why?
|
| Pulmonary Artery | 11 | 2011 | 323 | 0.560 |
Why?
|
| Swine | 54 | 2003 | 672 | 0.540 |
Why?
|
| Infant | 45 | 2011 | 2891 | 0.530 |
Why?
|
| Heart Defects, Congenital | 12 | 2006 | 596 | 0.520 |
Why?
|
| Cardiopulmonary Bypass | 14 | 2010 | 250 | 0.510 |
Why?
|
| Congresses as Topic | 1 | 2015 | 85 | 0.500 |
Why?
|
| Rheumatic Heart Disease | 2 | 2013 | 4 | 0.480 |
Why?
|
| Apolipoproteins E | 7 | 1999 | 92 | 0.480 |
Why?
|
| Polymorphism, Genetic | 8 | 2000 | 301 | 0.480 |
Why?
|
| Surgery Department, Hospital | 2 | 2010 | 19 | 0.470 |
Why?
|
| Publishing | 1 | 2015 | 89 | 0.470 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 281 | 0.470 |
Why?
|
| Heart Transplantation | 5 | 2008 | 328 | 0.450 |
Why?
|
| Postoperative Complications | 27 | 2018 | 1615 | 0.450 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2007 | 47 | 0.440 |
Why?
|
| Female | 95 | 2018 | 38074 | 0.440 |
Why?
|
| Male | 103 | 2018 | 37321 | 0.440 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 158 | 0.430 |
Why?
|
| South Carolina | 17 | 2013 | 2752 | 0.420 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2007 | 37 | 0.420 |
Why?
|
| Coronary Vessels | 3 | 2013 | 313 | 0.410 |
Why?
|
| Thoracic Diseases | 1 | 2011 | 10 | 0.390 |
Why?
|
| Specialties, Surgical | 1 | 2011 | 19 | 0.380 |
Why?
|
| Academies and Institutes | 1 | 2011 | 31 | 0.380 |
Why?
|
| Tricuspid Valve Insufficiency | 3 | 2009 | 25 | 0.380 |
Why?
|
| General Surgery | 2 | 2003 | 95 | 0.380 |
Why?
|
| Cardiomyopathy, Dilated | 13 | 1996 | 106 | 0.380 |
Why?
|
| Clinical Competence | 3 | 2013 | 657 | 0.360 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2011 | 45 | 0.360 |
Why?
|
| Education, Medical, Continuing | 1 | 2011 | 136 | 0.360 |
Why?
|
| Stroke Volume | 14 | 2003 | 586 | 0.360 |
Why?
|
| Reoperation | 17 | 2018 | 467 | 0.360 |
Why?
|
| History, 20th Century | 6 | 2010 | 248 | 0.360 |
Why?
|
| Endarterectomy, Carotid | 1 | 2011 | 110 | 0.350 |
Why?
|
| Mitral Valve Insufficiency | 8 | 2011 | 99 | 0.350 |
Why?
|
| Arrhythmias, Cardiac | 7 | 1994 | 239 | 0.350 |
Why?
|
| Thrombasthenia | 1 | 2009 | 3 | 0.340 |
Why?
|
| Carotid Stenosis | 1 | 2011 | 163 | 0.340 |
Why?
|
| Middle Aged | 58 | 2018 | 21147 | 0.330 |
Why?
|
| Wolff-Parkinson-White Syndrome | 7 | 1997 | 8 | 0.330 |
Why?
|
| Aortic Coarctation | 5 | 2004 | 37 | 0.320 |
Why?
|
| Tachycardia | 10 | 1994 | 53 | 0.320 |
Why?
|
| Child, Preschool | 35 | 2007 | 3187 | 0.320 |
Why?
|
| Tetralogy of Fallot | 5 | 2007 | 43 | 0.310 |
Why?
|
| Heart Septal Defects | 3 | 2010 | 27 | 0.310 |
Why?
|
| Ventricular Function, Left | 20 | 2003 | 481 | 0.300 |
Why?
|
| Heart Ventricles | 25 | 2000 | 738 | 0.300 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2003 | 100 | 0.300 |
Why?
|
| Bioprosthesis | 6 | 2010 | 101 | 0.300 |
Why?
|
| Cardiac Catheterization | 11 | 2013 | 419 | 0.300 |
Why?
|
| Sternum | 3 | 2000 | 19 | 0.300 |
Why?
|
| Child | 41 | 2006 | 6405 | 0.300 |
Why?
|
| Aortic Aneurysm | 2 | 2004 | 77 | 0.300 |
Why?
|
| Heart | 10 | 1995 | 850 | 0.300 |
Why?
|
| Protamines | 6 | 1997 | 14 | 0.290 |
Why?
|
| Aged | 40 | 2018 | 14862 | 0.290 |
Why?
|
| Coronary Disease | 6 | 1990 | 358 | 0.290 |
Why?
|
| Vasoconstriction | 2 | 2004 | 81 | 0.280 |
Why?
|
| Cardiography, Impedance | 4 | 1990 | 14 | 0.280 |
Why?
|
| Plethysmography, Impedance | 4 | 1990 | 17 | 0.280 |
Why?
|
| Hypertension, Pulmonary | 2 | 2005 | 232 | 0.270 |
Why?
|
| Adult | 50 | 2018 | 21403 | 0.270 |
Why?
|
| Transplantation | 1 | 2006 | 23 | 0.270 |
Why?
|
| Survival Analysis | 7 | 2018 | 714 | 0.260 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2004 | 134 | 0.260 |
Why?
|
| Mammary Arteries | 2 | 2004 | 18 | 0.260 |
Why?
|
| Heart Conduction System | 4 | 1997 | 119 | 0.260 |
Why?
|
| Echocardiography | 15 | 2004 | 515 | 0.260 |
Why?
|
| Retrospective Studies | 31 | 2011 | 7277 | 0.260 |
Why?
|
| Polyethylene Terephthalates | 5 | 2004 | 29 | 0.250 |
Why?
|
| Brachiocephalic Trunk | 2 | 2004 | 11 | 0.250 |
Why?
|
| Postoperative Hemorrhage | 3 | 2011 | 69 | 0.250 |
Why?
|
| Intraoperative Complications | 2 | 2004 | 129 | 0.250 |
Why?
|
| Schools, Medical | 2 | 2003 | 157 | 0.250 |
Why?
|
| Surgical Wound Infection | 3 | 2000 | 168 | 0.250 |
Why?
|
| Papaverine | 1 | 2004 | 10 | 0.250 |
Why?
|
| Animals | 76 | 2011 | 20881 | 0.250 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2004 | 12 | 0.250 |
Why?
|
| Hospitals, University | 5 | 2006 | 169 | 0.250 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 696 | 0.240 |
Why?
|
| Adolescent | 35 | 2018 | 8912 | 0.240 |
Why?
|
| Isoproterenol | 16 | 1998 | 163 | 0.230 |
Why?
|
| Catheterization | 3 | 1997 | 209 | 0.230 |
Why?
|
| Aneurysm | 1 | 2004 | 53 | 0.230 |
Why?
|
| Mitral Valve Stenosis | 4 | 1997 | 15 | 0.230 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 138 | 0.230 |
Why?
|
| Hypothermia, Induced | 6 | 1998 | 93 | 0.230 |
Why?
|
| Renal Dialysis | 3 | 2000 | 174 | 0.230 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2004 | 54 | 0.230 |
Why?
|
| Infant, Newborn | 20 | 2007 | 2455 | 0.220 |
Why?
|
| Aortic Valve Stenosis | 7 | 2013 | 177 | 0.220 |
Why?
|
| Ventricular Function, Right | 4 | 1992 | 103 | 0.210 |
Why?
|
| Matrix Metalloproteinases | 3 | 2010 | 223 | 0.210 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2004 | 186 | 0.200 |
Why?
|
| Cardiac Output | 10 | 1992 | 133 | 0.200 |
Why?
|
| Cryosurgery | 4 | 1997 | 53 | 0.200 |
Why?
|
| Treatment Outcome | 12 | 2011 | 7029 | 0.200 |
Why?
|
| Surgical Flaps | 3 | 2000 | 120 | 0.200 |
Why?
|
| Genotype | 8 | 2000 | 786 | 0.200 |
Why?
|
| Follow-Up Studies | 20 | 2010 | 3259 | 0.190 |
Why?
|
| Risk Factors | 15 | 2018 | 5731 | 0.190 |
Why?
|
| Receptors, Adrenergic, beta | 9 | 1998 | 153 | 0.180 |
Why?
|
| Heart Function Tests | 2 | 1990 | 33 | 0.180 |
Why?
|
| Time Factors | 18 | 2013 | 4655 | 0.180 |
Why?
|
| Physician Executives | 1 | 2000 | 21 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2000 | 38 | 0.180 |
Why?
|
| Potassium | 4 | 2000 | 168 | 0.180 |
Why?
|
| Factor VIIa | 2 | 2011 | 25 | 0.170 |
Why?
|
| Cardiac Pacing, Artificial | 11 | 1997 | 174 | 0.170 |
Why?
|
| Hemodynamics | 13 | 2006 | 705 | 0.170 |
Why?
|
| alpha-Macroglobulins | 1 | 1999 | 8 | 0.170 |
Why?
|
| Program Development | 3 | 2013 | 240 | 0.170 |
Why?
|
| Odds Ratio | 5 | 2011 | 880 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2003 | 277 | 0.170 |
Why?
|
| tau Proteins | 1 | 1999 | 61 | 0.160 |
Why?
|
| Heart Neoplasms | 4 | 1991 | 33 | 0.160 |
Why?
|
| Heart Failure | 10 | 2006 | 1180 | 0.160 |
Why?
|
| Butyrylcholinesterase | 1 | 1998 | 9 | 0.160 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 1995 | 72 | 0.160 |
Why?
|
| United States | 7 | 2014 | 7367 | 0.160 |
Why?
|
| Lung Diseases | 3 | 1989 | 175 | 0.160 |
Why?
|
| Education, Medical | 1 | 2000 | 147 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2013 | 706 | 0.150 |
Why?
|
| Endothelin A Receptor Antagonists | 2 | 2008 | 22 | 0.150 |
Why?
|
| Myocardial Infarction | 4 | 2011 | 807 | 0.150 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 4848 | 0.150 |
Why?
|
| Aorta, Thoracic | 3 | 1994 | 211 | 0.150 |
Why?
|
| Population Surveillance | 1 | 1999 | 285 | 0.150 |
Why?
|
| Pacemaker, Artificial | 6 | 2007 | 157 | 0.140 |
Why?
|
| Electrocardiography | 10 | 1992 | 601 | 0.140 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 1851 | 0.140 |
Why?
|
| Survival Rate | 6 | 2000 | 1056 | 0.140 |
Why?
|
| Dogs | 14 | 1995 | 490 | 0.130 |
Why?
|
| Heart Injuries | 2 | 1993 | 25 | 0.130 |
Why?
|
| Credentialing | 1 | 1996 | 23 | 0.130 |
Why?
|
| Cor Triatriatum | 1 | 1995 | 5 | 0.130 |
Why?
|
| Coronary Circulation | 7 | 2003 | 136 | 0.130 |
Why?
|
| Thrombosis | 5 | 2008 | 218 | 0.130 |
Why?
|
| Virginia | 2 | 2010 | 45 | 0.130 |
Why?
|
| Electrophysiology | 4 | 1995 | 160 | 0.120 |
Why?
|
| Blood Pressure | 13 | 2007 | 1451 | 0.120 |
Why?
|
| Rhabdomyoma | 2 | 1991 | 7 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 3 | 2006 | 365 | 0.120 |
Why?
|
| Mentors | 2 | 2013 | 81 | 0.120 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 1994 | 24 | 0.120 |
Why?
|
| Hemofiltration | 1 | 1993 | 7 | 0.110 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1993 | 17 | 0.110 |
Why?
|
| Respiratory Tract Diseases | 1 | 1994 | 43 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2009 | 453 | 0.110 |
Why?
|
| Cryopreservation | 1 | 1994 | 103 | 0.110 |
Why?
|
| Cardiomyopathies | 6 | 1992 | 167 | 0.110 |
Why?
|
| Esophageal Diseases | 1 | 1994 | 95 | 0.110 |
Why?
|
| In Vitro Techniques | 11 | 1996 | 765 | 0.110 |
Why?
|
| Curriculum | 3 | 2013 | 575 | 0.110 |
Why?
|
| Pneumonectomy | 2 | 1992 | 79 | 0.110 |
Why?
|
| Career Choice | 1 | 2014 | 98 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 1993 | 45 | 0.110 |
Why?
|
| Alleles | 6 | 2000 | 386 | 0.110 |
Why?
|
| Cause of Death | 3 | 2000 | 241 | 0.110 |
Why?
|
| Heart Atria | 5 | 2006 | 206 | 0.110 |
Why?
|
| Pericardium | 2 | 1999 | 97 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2000 | 1553 | 0.100 |
Why?
|
| Cardiovascular Agents | 2 | 2007 | 82 | 0.100 |
Why?
|
| Actuarial Analysis | 2 | 2003 | 23 | 0.100 |
Why?
|
| Warfarin | 2 | 2006 | 93 | 0.100 |
Why?
|
| Aortic Diseases | 2 | 2008 | 113 | 0.100 |
Why?
|
| Basement Membrane | 1 | 1991 | 48 | 0.100 |
Why?
|
| Manikins | 1 | 2011 | 42 | 0.100 |
Why?
|
| Disaster Planning | 1 | 1993 | 105 | 0.100 |
Why?
|
| Heart Aneurysm | 1 | 1991 | 21 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1991 | 46 | 0.100 |
Why?
|
| Cytokines | 3 | 2010 | 866 | 0.100 |
Why?
|
| Triiodothyronine, Reverse | 3 | 1995 | 4 | 0.100 |
Why?
|
| Hospital Costs | 2 | 2011 | 117 | 0.100 |
Why?
|
| Gene Frequency | 4 | 2000 | 207 | 0.100 |
Why?
|
| Embolism | 2 | 2006 | 45 | 0.100 |
Why?
|
| Hemostatic Techniques | 1 | 2011 | 23 | 0.100 |
Why?
|
| Patient Selection | 3 | 2011 | 592 | 0.090 |
Why?
|
| Isoxazoles | 2 | 2008 | 22 | 0.090 |
Why?
|
| Hemostatics | 1 | 2011 | 47 | 0.090 |
Why?
|
| Cardioplegic Solutions | 4 | 1998 | 15 | 0.090 |
Why?
|
| Calcium | 7 | 2003 | 929 | 0.090 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2007 | 36 | 0.090 |
Why?
|
| Propensity Score | 1 | 2011 | 117 | 0.090 |
Why?
|
| Blood Vessel Prosthesis | 7 | 1987 | 182 | 0.090 |
Why?
|
| Disasters | 1 | 1993 | 204 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 252 | 0.090 |
Why?
|
| Drug Costs | 1 | 2011 | 87 | 0.090 |
Why?
|
| Extravascular Lung Water | 1 | 1990 | 5 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2008 | 1745 | 0.090 |
Why?
|
| Propranolol | 2 | 2007 | 103 | 0.090 |
Why?
|
| Thiophenes | 2 | 2008 | 76 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2010 | 95 | 0.090 |
Why?
|
| Ventricular Remodeling | 2 | 2003 | 318 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2011 | 2007 | 0.090 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2003 | 84 | 0.090 |
Why?
|
| Radionuclide Ventriculography | 1 | 1990 | 6 | 0.090 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2010 | 48 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2010 | 127 | 0.090 |
Why?
|
| Aprotinin | 1 | 2010 | 55 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 1991 | 133 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 1990 | 51 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1990 | 100 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2006 | 373 | 0.090 |
Why?
|
| Computer Systems | 1 | 1990 | 42 | 0.090 |
Why?
|
| Tranexamic Acid | 1 | 2010 | 37 | 0.090 |
Why?
|
| Antifibrinolytic Agents | 1 | 2010 | 52 | 0.090 |
Why?
|
| Leadership | 1 | 2011 | 136 | 0.090 |
Why?
|
| Workload | 2 | 2013 | 103 | 0.090 |
Why?
|
| Creatine Kinase | 3 | 2003 | 46 | 0.090 |
Why?
|
| Extracellular Space | 1 | 1989 | 121 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 1993 | 400 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2011 | 254 | 0.080 |
Why?
|
| Prazosin | 1 | 1989 | 10 | 0.080 |
Why?
|
| Osteonecrosis | 1 | 1989 | 20 | 0.080 |
Why?
|
| Platelet Transfusion | 1 | 2009 | 21 | 0.080 |
Why?
|
| Apolipoprotein E4 | 3 | 1998 | 31 | 0.080 |
Why?
|
| Age of Onset | 3 | 1999 | 188 | 0.080 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1989 | 61 | 0.080 |
Why?
|
| Pseudomonas Infections | 3 | 1991 | 83 | 0.080 |
Why?
|
| Blood Loss, Surgical | 1 | 2009 | 79 | 0.080 |
Why?
|
| Operating Rooms | 1 | 1990 | 108 | 0.080 |
Why?
|
| Echocardiography, Doppler | 3 | 2000 | 87 | 0.080 |
Why?
|
| Reference Values | 2 | 2000 | 579 | 0.080 |
Why?
|
| Prosthesis Failure | 3 | 2010 | 130 | 0.080 |
Why?
|
| Critical Care | 1 | 2011 | 263 | 0.080 |
Why?
|
| Introns | 2 | 1999 | 68 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2004 | 317 | 0.080 |
Why?
|
| Microscopy, Electron | 8 | 1994 | 351 | 0.080 |
Why?
|
| Heart Block | 2 | 2007 | 49 | 0.080 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 3 | 1994 | 12 | 0.080 |
Why?
|
| Vascular Resistance | 5 | 2007 | 179 | 0.080 |
Why?
|
| Electric Countershock | 4 | 2004 | 130 | 0.080 |
Why?
|
| Forecasting | 2 | 2003 | 277 | 0.080 |
Why?
|
| Prosthesis Design | 5 | 2010 | 301 | 0.080 |
Why?
|
| Florida | 2 | 2000 | 221 | 0.080 |
Why?
|
| Muscles | 3 | 1994 | 158 | 0.080 |
Why?
|
| Transplantation, Heterologous | 4 | 1986 | 122 | 0.070 |
Why?
|
| Premedication | 1 | 2007 | 49 | 0.070 |
Why?
|
| Potassium Compounds | 2 | 1998 | 7 | 0.070 |
Why?
|
| Femoral Artery | 4 | 1997 | 139 | 0.070 |
Why?
|
| Ischemic Preconditioning, Myocardial | 2 | 1997 | 7 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2000 | 295 | 0.070 |
Why?
|
| Spinal Cord | 2 | 1989 | 244 | 0.070 |
Why?
|
| Esophagus | 2 | 1989 | 303 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 3 | 1987 | 32 | 0.070 |
Why?
|
| Radioisotopes | 2 | 1986 | 40 | 0.070 |
Why?
|
| Anticoagulants | 4 | 2006 | 356 | 0.070 |
Why?
|
| Bronchiectasis | 2 | 1989 | 25 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 189 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 5 | 1998 | 92 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2007 | 75 | 0.070 |
Why?
|
| Cells, Cultured | 12 | 2000 | 2673 | 0.070 |
Why?
|
| Sudden Infant Death | 1 | 1986 | 6 | 0.070 |
Why?
|
| Muscle Contraction | 3 | 1997 | 210 | 0.070 |
Why?
|
| Heart Diseases | 2 | 2008 | 276 | 0.070 |
Why?
|
| Brachytherapy | 1 | 1986 | 79 | 0.070 |
Why?
|
| Comprehensive Health Care | 1 | 2006 | 26 | 0.070 |
Why?
|
| Renal Replacement Therapy | 1 | 2006 | 40 | 0.070 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2006 | 38 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 626 | 0.070 |
Why?
|
| Random Allocation | 6 | 2003 | 442 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 2010 | 242 | 0.060 |
Why?
|
| Prosthesis Fitting | 1 | 2005 | 6 | 0.060 |
Why?
|
| Equipment Design | 1 | 2007 | 500 | 0.060 |
Why?
|
| Triiodothyronine | 2 | 1995 | 22 | 0.060 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2006 | 117 | 0.060 |
Why?
|
| Aorta | 5 | 1989 | 316 | 0.060 |
Why?
|
| Spasm | 1 | 2004 | 18 | 0.060 |
Why?
|
| Age Factors | 5 | 2011 | 1864 | 0.060 |
Why?
|
| Foreign Bodies | 1 | 1985 | 58 | 0.060 |
Why?
|
| Ventricular Function | 6 | 1994 | 93 | 0.060 |
Why?
|
| Injections | 1 | 2004 | 119 | 0.060 |
Why?
|
| Demography | 1 | 2005 | 279 | 0.060 |
Why?
|
| Paraplegia | 1 | 1984 | 28 | 0.060 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 49 | 0.060 |
Why?
|
| Postoperative Period | 3 | 2010 | 238 | 0.060 |
Why?
|
| Disease Management | 1 | 2006 | 248 | 0.060 |
Why?
|
| Postoperative Care | 4 | 2011 | 163 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 212 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 36 | 0.060 |
Why?
|
| North Carolina | 2 | 2003 | 224 | 0.060 |
Why?
|
| Rewarming | 4 | 1998 | 11 | 0.060 |
Why?
|
| Pulmonary Valve | 3 | 1994 | 40 | 0.060 |
Why?
|
| Atmospheric Pressure | 1 | 1983 | 8 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2010 | 2358 | 0.060 |
Why?
|
| Intraoperative Period | 3 | 2000 | 62 | 0.060 |
Why?
|
| Radioactive Tracers | 1 | 1983 | 5 | 0.060 |
Why?
|
| Fever | 1 | 1984 | 96 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1986 | 300 | 0.060 |
Why?
|
| Microspheres | 1 | 1983 | 59 | 0.050 |
Why?
|
| Adenosine | 4 | 1997 | 165 | 0.050 |
Why?
|
| Life Style | 1 | 2005 | 338 | 0.050 |
Why?
|
| Environment | 1 | 2003 | 115 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2004 | 140 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2010 | 3705 | 0.050 |
Why?
|
| Students, Medical | 1 | 2005 | 210 | 0.050 |
Why?
|
| Vena Cava, Inferior | 2 | 1989 | 41 | 0.050 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2003 | 59 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 792 | 0.050 |
Why?
|
| Collagen | 4 | 1999 | 636 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2003 | 84 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 308 | 0.050 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2002 | 10 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2003 | 85 | 0.050 |
Why?
|
| Radiography | 6 | 1998 | 572 | 0.050 |
Why?
|
| Thromboembolism | 5 | 1997 | 91 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 152 | 0.050 |
Why?
|
| Haplotypes | 2 | 1999 | 174 | 0.050 |
Why?
|
| Tachycardia, Ventricular | 2 | 1994 | 153 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2004 | 249 | 0.050 |
Why?
|
| Catheter Ablation | 2 | 1994 | 229 | 0.050 |
Why?
|
| Decision Making | 1 | 2005 | 410 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2003 | 2550 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2003 | 1040 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 1989 | 1173 | 0.050 |
Why?
|
| Blood Coagulation Tests | 2 | 2008 | 31 | 0.050 |
Why?
|
| Chronic Disease | 9 | 1993 | 1330 | 0.050 |
Why?
|
| Heart Massage | 1 | 1980 | 3 | 0.050 |
Why?
|
| Wounds, Gunshot | 2 | 1993 | 48 | 0.050 |
Why?
|
| Equipment Failure | 3 | 1993 | 112 | 0.050 |
Why?
|
| Body Temperature | 2 | 1998 | 116 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 504 | 0.050 |
Why?
|
| Heparin | 4 | 1995 | 205 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 659 | 0.050 |
Why?
|
| Angina Pectoris | 1 | 2000 | 61 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2013 | 502 | 0.050 |
Why?
|
| Indicator Dilution Techniques | 2 | 1990 | 8 | 0.040 |
Why?
|
| Debridement | 2 | 1991 | 55 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2000 | 15 | 0.040 |
Why?
|
| Nifedipine | 1 | 2000 | 40 | 0.040 |
Why?
|
| Diltiazem | 1 | 2000 | 26 | 0.040 |
Why?
|
| Kidney | 2 | 2002 | 945 | 0.040 |
Why?
|
| Amlodipine | 1 | 2000 | 31 | 0.040 |
Why?
|
| Receptors, Endothelin | 1 | 2000 | 30 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2000 | 270 | 0.040 |
Why?
|
| Phospholipases A | 1 | 1999 | 41 | 0.040 |
Why?
|
| Valine | 1 | 1999 | 43 | 0.040 |
Why?
|
| Hospital Administration | 1 | 2000 | 43 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 188 | 0.040 |
Why?
|
| Radial Artery | 1 | 2000 | 43 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2000 | 117 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 138 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2000 | 122 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 163 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2011 | 742 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 1999 | 91 | 0.040 |
Why?
|
| Certification | 1 | 2000 | 66 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 1999 | 106 | 0.040 |
Why?
|
| Tetrazoles | 1 | 1999 | 160 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 2 | 1982 | 91 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2000 | 213 | 0.040 |
Why?
|
| Video Recording | 3 | 2013 | 145 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1999 | 155 | 0.040 |
Why?
|
| Pulmonary Embolism | 2 | 1998 | 253 | 0.040 |
Why?
|
| Smoking Prevention | 1 | 2000 | 259 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 231 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 2 | 1989 | 27 | 0.040 |
Why?
|
| Myxoma | 1 | 1978 | 17 | 0.040 |
Why?
|
| Sex Distribution | 1 | 1999 | 274 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 1978 | 23 | 0.040 |
Why?
|
| Hypertonic Solutions | 1 | 1998 | 17 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 235 | 0.040 |
Why?
|
| Community Health Centers | 1 | 1998 | 26 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 1998 | 90 | 0.040 |
Why?
|
| Young Adult | 3 | 2018 | 5717 | 0.040 |
Why?
|
| Stroke | 1 | 2011 | 2163 | 0.040 |
Why?
|
| Aortic Stenosis, Subvalvular | 2 | 1990 | 8 | 0.040 |
Why?
|
| Action Potentials | 2 | 2000 | 223 | 0.040 |
Why?
|
| Resorcinols | 1 | 1997 | 8 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1997 | 15 | 0.040 |
Why?
|
| Gelatin | 1 | 1997 | 14 | 0.040 |
Why?
|
| Dipyridamole | 1 | 1997 | 26 | 0.040 |
Why?
|
| Gene Expression | 1 | 2000 | 770 | 0.040 |
Why?
|
| Glutaral | 1 | 1997 | 41 | 0.040 |
Why?
|
| Tissue Adhesives | 1 | 1997 | 17 | 0.040 |
Why?
|
| alpha 1-Antichymotrypsin | 1 | 1997 | 7 | 0.040 |
Why?
|
| Formaldehyde | 1 | 1997 | 48 | 0.040 |
Why?
|
| Incidence | 1 | 2001 | 1603 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 1992 | 236 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1997 | 20 | 0.040 |
Why?
|
| Linear Models | 2 | 2000 | 521 | 0.040 |
Why?
|
| Nuclear Family | 1 | 1996 | 16 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 546 | 0.040 |
Why?
|
| Blood | 1 | 1996 | 40 | 0.040 |
Why?
|
| Heparin Antagonists | 1 | 1996 | 2 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 1997 | 72 | 0.030 |
Why?
|
| Baltimore | 1 | 1996 | 34 | 0.030 |
Why?
|
| Veins | 3 | 1978 | 68 | 0.030 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 1976 | 5 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 1990 | 116 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 615 | 0.030 |
Why?
|
| Aspirin | 1 | 1997 | 295 | 0.030 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1976 | 47 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2008 | 344 | 0.030 |
Why?
|
| Smoking | 2 | 2000 | 1452 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2006 | 349 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 1990 | 98 | 0.030 |
Why?
|
| Heart Rate | 5 | 2003 | 568 | 0.030 |
Why?
|
| Peptic Ulcer | 2 | 1972 | 37 | 0.030 |
Why?
|
| Family | 1 | 1996 | 293 | 0.030 |
Why?
|
| Thrombin | 1 | 1995 | 117 | 0.030 |
Why?
|
| Assisted Circulation | 1 | 1994 | 7 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 2800 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1994 | 289 | 0.030 |
Why?
|
| Hydroxyethyl Starch Derivatives | 2 | 1985 | 24 | 0.030 |
Why?
|
| Starch | 2 | 1985 | 18 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 1994 | 242 | 0.030 |
Why?
|
| Mutation | 1 | 1999 | 1213 | 0.030 |
Why?
|
| Centrifugation | 1 | 1993 | 16 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 1994 | 236 | 0.030 |
Why?
|
| Muscle Proteins | 2 | 1994 | 94 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 42 | 0.030 |
Why?
|
| Systole | 2 | 1992 | 149 | 0.030 |
Why?
|
| Platelet Count | 1 | 1993 | 100 | 0.030 |
Why?
|
| Fibrinogen | 1 | 1993 | 87 | 0.030 |
Why?
|
| Diastole | 2 | 1992 | 161 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2013 | 70 | 0.030 |
Why?
|
| Microscopy, Video | 3 | 1998 | 27 | 0.030 |
Why?
|
| Thoracotomy | 1 | 1993 | 25 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 1984 | 38 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 64 | 0.030 |
Why?
|
| Sarcomeres | 1 | 1993 | 32 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 1993 | 80 | 0.030 |
Why?
|
| Maintenance and Engineering, Hospital | 1 | 1993 | 3 | 0.030 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1993 | 14 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 104 | 0.030 |
Why?
|
| Liver Failure | 1 | 1993 | 27 | 0.030 |
Why?
|
| Electric Power Supplies | 1 | 1993 | 26 | 0.030 |
Why?
|
| Oxygen | 3 | 2006 | 386 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 1997 | 617 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2013 | 110 | 0.030 |
Why?
|
| Cardiotonic Agents | 2 | 2007 | 71 | 0.030 |
Why?
|
| Recurrence | 4 | 1990 | 948 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 371 | 0.030 |
Why?
|
| Safety | 1 | 1993 | 145 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 330 | 0.030 |
Why?
|
| Central Venous Pressure | 1 | 1992 | 11 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1992 | 20 | 0.030 |
Why?
|
| Cardiac Volume | 1 | 1992 | 21 | 0.030 |
Why?
|
| Diverticulum | 1 | 1992 | 29 | 0.030 |
Why?
|
| Electric Stimulation Therapy | 1 | 1994 | 147 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 1991 | 951 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 1992 | 87 | 0.030 |
Why?
|
| Quality of Life | 1 | 2000 | 1515 | 0.030 |
Why?
|
| Pulmonary Circulation | 3 | 1989 | 79 | 0.030 |
Why?
|
| Cardiac Output, Low | 1 | 1992 | 52 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 1996 | 1034 | 0.030 |
Why?
|
| Teaching | 1 | 2013 | 169 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2013 | 186 | 0.020 |
Why?
|
| Feedback | 1 | 2011 | 90 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 1991 | 23 | 0.020 |
Why?
|
| Laminin | 1 | 1991 | 62 | 0.020 |
Why?
|
| Trauma Centers | 1 | 1993 | 197 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2000 | 1034 | 0.020 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1971 | 26 | 0.020 |
Why?
|
| Signal Transduction | 2 | 1998 | 2689 | 0.020 |
Why?
|
| Motor Skills | 1 | 2011 | 88 | 0.020 |
Why?
|
| Fibronectins | 1 | 1991 | 130 | 0.020 |
Why?
|
| Health Care Costs | 1 | 1994 | 346 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 69 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 150 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2077 | 0.020 |
Why?
|
| Shock, Septic | 1 | 1991 | 101 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1991 | 141 | 0.020 |
Why?
|
| Hematocrit | 1 | 1990 | 70 | 0.020 |
Why?
|
| Mathematics | 1 | 1990 | 83 | 0.020 |
Why?
|
| Length of Stay | 4 | 2001 | 780 | 0.020 |
Why?
|
| Blood Volume | 1 | 1990 | 47 | 0.020 |
Why?
|
| Hypertension | 1 | 1999 | 1535 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1989 | 10 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1990 | 87 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1989 | 30 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1989 | 40 | 0.020 |
Why?
|
| Respiratory Paralysis | 2 | 1987 | 10 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1989 | 40 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 238 | 0.020 |
Why?
|
| Learning | 1 | 2011 | 186 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 245 | 0.020 |
Why?
|
| Methods | 3 | 1984 | 156 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 306 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 1989 | 51 | 0.020 |
Why?
|
| Antibiotics, Antitubercular | 1 | 1989 | 18 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 2 | 1987 | 55 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1989 | 70 | 0.020 |
Why?
|
| Hemoptysis | 1 | 1989 | 28 | 0.020 |
Why?
|
| High-Frequency Jet Ventilation | 1 | 1989 | 1 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1990 | 133 | 0.020 |
Why?
|
| Bronchial Diseases | 1 | 1989 | 9 | 0.020 |
Why?
|
| Intubation | 1 | 1989 | 20 | 0.020 |
Why?
|
| Fistula | 1 | 1989 | 29 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 504 | 0.020 |
Why?
|
| Heart Septum | 1 | 1989 | 84 | 0.020 |
Why?
|
| Pleural Diseases | 1 | 1989 | 20 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1989 | 25 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 1989 | 53 | 0.020 |
Why?
|
| Tricuspid Valve | 2 | 1985 | 42 | 0.020 |
Why?
|
| Endothelins | 1 | 2008 | 57 | 0.020 |
Why?
|
| Ventilators, Mechanical | 1 | 1988 | 13 | 0.020 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 1988 | 2 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 1972 | 824 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 1988 | 99 | 0.020 |
Why?
|
| Isotonic Solutions | 2 | 1985 | 25 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1988 | 31 | 0.020 |
Why?
|
| Extracorporeal Circulation | 1 | 1968 | 26 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 1989 | 150 | 0.020 |
Why?
|
| Subclavian Artery | 1 | 1987 | 30 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2006 | 275 | 0.020 |
Why?
|
| Sarcolemma | 2 | 2000 | 16 | 0.020 |
Why?
|
| Pneumonia | 1 | 2008 | 110 | 0.020 |
Why?
|
| Myocardial Reperfusion | 2 | 1998 | 32 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1046 | 0.020 |
Why?
|
| Capillaries | 3 | 1992 | 105 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1994 | 219 | 0.020 |
Why?
|
| Iridium | 1 | 1986 | 1 | 0.020 |
Why?
|
| Calcium Channels | 2 | 1998 | 59 | 0.020 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1986 | 42 | 0.020 |
Why?
|
| Thoracic Arteries | 1 | 1986 | 10 | 0.020 |
Why?
|
| Isomerism | 2 | 1997 | 63 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 567 | 0.020 |
Why?
|
| Lymphedema | 1 | 1986 | 6 | 0.020 |
Why?
|
| Pigmentation Disorders | 1 | 1986 | 11 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1986 | 119 | 0.020 |
Why?
|
| Palliative Care | 1 | 1989 | 271 | 0.020 |
Why?
|
| Nail Diseases | 1 | 1986 | 13 | 0.020 |
Why?
|
| Diaphragmatic Eventration | 1 | 1986 | 9 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 1986 | 61 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 2000 | 164 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2008 | 384 | 0.020 |
Why?
|
| Quinidine | 1 | 1986 | 15 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1986 | 47 | 0.020 |
Why?
|
| Amiodarone | 1 | 1986 | 21 | 0.020 |
Why?
|
| Procainamide | 1 | 1986 | 12 | 0.020 |
Why?
|
| Adenylyl Cyclases | 2 | 1998 | 94 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 1986 | 74 | 0.020 |
Why?
|
| Cell Separation | 2 | 1998 | 132 | 0.020 |
Why?
|
| Rabbits | 2 | 1996 | 509 | 0.020 |
Why?
|
| Graft Rejection | 1 | 1988 | 458 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 232 | 0.020 |
Why?
|
| Albumins | 1 | 1985 | 72 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 652 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 1985 | 72 | 0.020 |
Why?
|
| Esophagitis | 1 | 1985 | 45 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 392 | 0.020 |
Why?
|
| Algorithms | 1 | 1991 | 1196 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 1985 | 49 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 1593 | 0.020 |
Why?
|
| Constriction | 1 | 1984 | 37 | 0.010 |
Why?
|
| Cardiac Glycosides | 2 | 1995 | 8 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 20 | 0.010 |
Why?
|
| Neurons | 1 | 1989 | 881 | 0.010 |
Why?
|
| Troponin I | 1 | 2003 | 34 | 0.010 |
Why?
|
| Benzenesulfonates | 1 | 2003 | 30 | 0.010 |
Why?
|
| Logistic Models | 2 | 1998 | 1420 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1996 | 396 | 0.010 |
Why?
|
| Exercise Test | 1 | 1984 | 242 | 0.010 |
Why?
|
| Biological Transport | 1 | 2003 | 210 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 194 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1983 | 34 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 622 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1983 | 166 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2000 | 1342 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 137 | 0.010 |
Why?
|
| Plasma Substitutes | 1 | 1982 | 15 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2003 | 82 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1993 | 276 | 0.010 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1982 | 16 | 0.010 |
Why?
|
| Xanthines | 1 | 2002 | 17 | 0.010 |
Why?
|
| Piperazines | 1 | 2003 | 206 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1982 | 123 | 0.010 |
Why?
|
| Acute Disease | 1 | 1983 | 658 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 1985 | 297 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 2001 | 72 | 0.010 |
Why?
|
| Scotland | 1 | 2000 | 18 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1980 | 168 | 0.010 |
Why?
|
| Nurse-Patient Relations | 1 | 2000 | 34 | 0.010 |
Why?
|
| Microdialysis | 1 | 2000 | 147 | 0.010 |
Why?
|
| Nurse Midwives | 1 | 2000 | 21 | 0.010 |
Why?
|
| Codon | 1 | 2000 | 21 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1984 | 848 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2000 | 43 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1999 | 16 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 1999 | 33 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1999 | 44 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2000 | 85 | 0.010 |
Why?
|
| Ion Channels | 1 | 2000 | 72 | 0.010 |
Why?
|
| Receptors, Angiotensin | 1 | 1999 | 59 | 0.010 |
Why?
|
| Valsartan | 1 | 1999 | 99 | 0.010 |
Why?
|
| Mortality | 1 | 1980 | 163 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 1038 | 0.010 |
Why?
|
| Kinetics | 2 | 1992 | 1047 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2000 | 102 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1980 | 296 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1992 | 1174 | 0.010 |
Why?
|
| Pancreas | 1 | 1999 | 225 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1978 | 37 | 0.010 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1998 | 10 | 0.010 |
Why?
|
| Counseling | 1 | 2000 | 280 | 0.010 |
Why?
|
| Transposition of Great Vessels | 1 | 1978 | 51 | 0.010 |
Why?
|
| Colforsin | 1 | 1998 | 42 | 0.010 |
Why?
|
| Calcium Channel Agonists | 1 | 1998 | 18 | 0.010 |
Why?
|
| Fibrosis | 1 | 1999 | 371 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1997 | 138 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 1997 | 28 | 0.010 |
Why?
|
| Endocarditis | 1 | 1977 | 14 | 0.010 |
Why?
|
| Picolines | 1 | 1996 | 8 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 119 | 0.010 |
Why?
|
| Pyrans | 1 | 1996 | 16 | 0.010 |
Why?
|
| Calcinosis | 1 | 1978 | 241 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1641 | 0.010 |
Why?
|
| Health Behavior | 1 | 2000 | 458 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 304 | 0.010 |
Why?
|
| Biopsy | 1 | 1998 | 540 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1996 | 55 | 0.010 |
Why?
|
| Venae Cavae | 1 | 1976 | 16 | 0.010 |
Why?
|
| Motivation | 1 | 2000 | 561 | 0.010 |
Why?
|
| Culture Media | 1 | 1996 | 155 | 0.010 |
Why?
|
| Microscopy | 1 | 1996 | 64 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1996 | 57 | 0.010 |
Why?
|
| Cell Size | 1 | 1996 | 76 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1997 | 791 | 0.010 |
Why?
|
| Rats | 2 | 1997 | 5300 | 0.010 |
Why?
|
| Syndrome | 2 | 1986 | 255 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 282 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 314 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1982 | 1026 | 0.010 |
Why?
|
| Hirudins | 1 | 1995 | 32 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1995 | 223 | 0.010 |
Why?
|
| Ligation | 1 | 1975 | 83 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1996 | 189 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 172 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 2334 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1975 | 145 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1994 | 29 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1994 | 20 | 0.010 |
Why?
|
| Lung | 2 | 1991 | 849 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1994 | 24 | 0.010 |
Why?
|
| Textiles | 1 | 1973 | 3 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1992 | 42 | 0.010 |
Why?
|
| Body Water | 1 | 1992 | 35 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1976 | 301 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 689 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 109 | 0.010 |
Why?
|
| Prognosis | 2 | 1988 | 2093 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1992 | 2223 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 2083 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1993 | 218 | 0.010 |
Why?
|
| Organ Size | 1 | 1992 | 242 | 0.010 |
Why?
|
| Ouabain | 1 | 1992 | 32 | 0.010 |
Why?
|
| Arterioles | 1 | 1992 | 40 | 0.010 |
Why?
|
| Hospitals | 1 | 1994 | 265 | 0.010 |
Why?
|
| Vagotomy | 1 | 1971 | 9 | 0.010 |
Why?
|
| Gastrectomy | 1 | 1971 | 24 | 0.010 |
Why?
|
| Autopsy | 1 | 1971 | 56 | 0.010 |
Why?
|
| Intestinal Perforation | 1 | 1971 | 35 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1990 | 149 | 0.010 |
Why?
|
| Hamartoma | 1 | 1990 | 24 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1990 | 72 | 0.010 |
Why?
|
| Endocardium | 1 | 1990 | 101 | 0.010 |
Why?
|
| DNA | 1 | 1992 | 597 | 0.010 |
Why?
|
| Cytarabine | 1 | 1989 | 44 | 0.010 |
Why?
|
| Digoxin | 1 | 1989 | 24 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1989 | 358 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1989 | 19 | 0.010 |
Why?
|
| Hemothorax | 1 | 1989 | 9 | 0.010 |
Why?
|
| Proteins | 1 | 1992 | 474 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1989 | 62 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1989 | 42 | 0.010 |
Why?
|
| Hematoma | 1 | 1989 | 47 | 0.010 |
Why?
|
| DNA Replication | 1 | 1989 | 167 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1989 | 78 | 0.010 |
Why?
|
| Aortography | 1 | 1989 | 72 | 0.010 |
Why?
|
| Cell Division | 1 | 1989 | 541 | 0.010 |
Why?
|
| Emergencies | 1 | 1989 | 107 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1968 | 41 | 0.000 |
Why?
|
| Cineangiography | 1 | 1987 | 15 | 0.000 |
Why?
|
| Electrocoagulation | 1 | 1988 | 35 | 0.000 |
Why?
|
| Blood Flow Velocity | 1 | 1988 | 172 | 0.000 |
Why?
|
| Ventricular Fibrillation | 1 | 1968 | 85 | 0.000 |
Why?
|
| Shock, Hemorrhagic | 1 | 1967 | 33 | 0.000 |
Why?
|
| Sex Factors | 1 | 1971 | 1266 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1968 | 258 | 0.000 |
Why?
|
| Papio | 1 | 1986 | 27 | 0.000 |
Why?
|
| Endothelium | 1 | 1986 | 98 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1986 | 97 | 0.000 |
Why?
|
| Body Fluids | 1 | 1985 | 41 | 0.000 |
Why?
|
| Blood Coagulation Factors | 1 | 1985 | 44 | 0.000 |
Why?
|
| Colloids | 1 | 1985 | 43 | 0.000 |
Why?
|
| Arm | 1 | 1984 | 59 | 0.000 |
Why?
|
| Heart Murmurs | 1 | 1984 | 6 | 0.000 |
Why?
|
| Posture | 1 | 1984 | 107 | 0.000 |
Why?
|
| Abscess | 1 | 1984 | 37 | 0.000 |
Why?
|
| Leg | 1 | 1984 | 191 | 0.000 |
Why?
|
| Mice | 1 | 1989 | 8474 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1978 | 102 | 0.000 |
Why?
|
| Pulmonary Heart Disease | 1 | 1977 | 3 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1978 | 156 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1978 | 328 | 0.000 |
Why?
|
| Iliac Artery | 1 | 1975 | 44 | 0.000 |
Why?
|
| Cattle | 1 | 1975 | 475 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1977 | 1140 | 0.000 |
Why?
|
| Toxins, Biological | 1 | 1967 | 23 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1967 | 144 | 0.000 |
Why?
|
| Ischemia | 1 | 1967 | 229 | 0.000 |
Why?
|